Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN0W7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,470
Award facts
- Contract value 100% obligated
- $11,470.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,470 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on January 22, 2026, with completion expected by January 23, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company Cencora, Inc. (doing business as AmerisourceBergen) providing corporate oversight. Mounjaro is a tirzepatide-based diabetes and weight management medication delivered via injectable pen, critical for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at $999,999,999 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical commodities globally to military treatment facilities and federal healthcare programs. The parent organization, Cencora, Inc., maintains an even larger IDC with DLA valued at $999,999,999 through December 31, 2031, reflecting the company's significant role as a prime vendor in the federal pharmaceutical supply chain. These contracts enable efficient, flexible procurement of essential medications and medical supplies across multiple therapeutic domains to support defense healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FN0W7?
SPE2DR26FN0W7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FN0W7 worth?
The government has obligated $11,470 on SPE2DR26FN0W7.
Is contract SPE2DR26FN0W7 an order under another contract?
Yes. SPE2DR26FN0W7 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN0W7 competed?
The extent of competition for SPE2DR26FN0W7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award